Retrograde regulation of STIM1-Orai1 interaction and store-operated Ca2+ entry by calsequestrin

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Limin ^a   Zhang, Lane ^a   Li, Shu ^a   Zheng, Yuanyuan ^a   Yan, Xinxin ^a   Chen, Min ^a   Wang, Haoyang ^a   Putney, James W ^b   Luo, Dali ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CALSEQUESTRIN; MEMBRANE PROTEIN; ORAI1 PROTEIN, HUMAN; PROTEIN BINDING; STIM1 PROTEIN, HUMAN; STROMAL INTERACTION MOLECULE 1; TUMOR PROTEIN;

CHEMISTRY; DRUG EFFECTS; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE SILENCING; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION;

CALCIUM; CALCIUM CHANNELS; CALSEQUESTRIN; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; ORAI1 PROTEIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; STROMAL INTERACTION MOLECULE 1;

EID: 84934987293     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11349     Document Type: Article

References (40)

1. Putney, J. W. The physiological function of store-operated calcium entry. Neurochem. Res. 36, 1157-1165 (2011).
2. Feske, S. Calcium signalling in lymphocyte activation and disease. Nat Rev. Immunol. 7, 690-702 (2007).
3. Roos, J. et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 169, 435-445 (2005).
4. Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185 (2006).
5. Liou, J. et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 15, 1235-1241 (2005).
6. Lewis, R. S. The molecular choreography of a store-operated calcium channel. Nature 446, 284-287 (2007).
7. Vig, M. et al. CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr. Biol 16, 2073-2079 (2006).
8. Prakriya, M. et al. Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230-233 (2006).
9. Luik, R. M., Wu, M. M., Buchanan, J. & Lewis, R. S. The elementary unit of store-operated Ca2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J. Cell Biol 174, 815-825 (2006).
10. Fujii, Y. et al. Surf4 modulates STIM1-dependent calcium entry. Biochem. Biophys. Res. Commun. 422, 615-620 (2012).
11. Srikanth, S., Jung, H. J., Ribalet, B. & Gwack, Y. The Intracellular Loop of Orai1 Plays a Central Role in Fast Inactivation of Ca2+ Release-activated Ca2+ Channels. J. Biol. Chem. 285, 5066-5075 (2010).
12. Sharma, S. et al. An siRNA screen for NFAT activation identifies septins as coordinators of store-operated Ca entry. Nature 499, 238-242 (2013).
13. Campbell, K. P., MacLennan, D. H., Jorgensen, A. O. & Mintzer, M. C. Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53, 000 dalton glycoprotein. J. Biol. Chem. 258, 1197-1204 (1983).
14. Wei, L., Hanna, A. D., Beard, N. A. & Dulhunty, A. F. Unique isoform-specific properties of calsequestrin in the heart and skeletal muscle. Cell Calcium 45, 474-484 (2009).
15. Lee, J. M. et al. Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin. J. Biol. Chem. 279, 6994-7000 (2004).
16. Kobayashi, Y. M., Alseikhan, B. A. & Jones, L. R. Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction. J. Biol. Chem. 275, 17639-17646 (2000).
17. Gyorke, I., Hester, N., Jones, L. R. & Gyorke, S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys. J. 86, 2121-2128 (2004).
18. Beard, N. A. et al. Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation. Biophys. J. 88, 3444-3454 (2005).
19. Wang, S. et al. Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat. Struct. Biol. 5, 476-483 (1998).
20. Yano, K. & Zarain-Herzberg, A. Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol. Cell Biochem. 135, 61-70 (1994).
21. He, Z., Dunker, A. K., Wesson, C. R. & Trumble, W. R. Ca(2+ )-induced folding and aggregation of skeletal muscle sarcoplasmic reticulum calsequestrin. The involvement of the trifluoperazine-binding site. J. Biol. Chem. 268, 24635-24641 (1993).
22. Dainese, M. et al. Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice. FASEB J. 23, 1710-1720 (2009).
23. MacLennan, D. H. & Zvaritch, E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim. Biophys. Acta 1813, 948-964 (2011).
24. Shin, D. W. et al. A retrograde signal from calsequestrin for the regulation of store-operated Ca2+ entry in skeletal muscle. J. Biol. Chem. 278, 3286-3292 (2003).
25. Zhao, X. et al. Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression. Biophys. J. 99, 1556-1564 (2010).
26. Zhu, Z. et al. Potential regulatory role of calsequestrin in platelet Ca(2+ ) homeostasis and its association with platelet hyperactivity in diabetes mellitus. J. Thromb. Haemost. 10, 116-124 (2012).
27. Liou, J., Fivaz, M., Inoue, T. & Meyer, T. Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2+ store depletion. Proc Natl Acad Sci U S A 104, 9301-9306 (2007).
28. Charlier, H. A. Jr. et al. Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine. Mol. Pharmacol. 67, 1505-1512 (2005).
29. Roufogalis, B. D., Minocherhomjee, A. M. & Al-Jobore, A. Pharmacological antagonism of calmodulin. Can. J. Biochem. Cell Biol. 61, 927-933 (1983).
30. Hallam, T. J. & Rink, T. J. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Letters 186, 175-179 (1985).
31. Shuttleworth, T. J. Temporal relationships between Ca2+ store mobilization and Ca2+ entry in an exocrine cell. Cell Calcium 15, 457-466 (1994).
32. Hlavacek, W. S., Posner, R. G. & Perelson, A. S. Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors. Biophys. J. 76, 3031-3043 (1999).
33. Royer, L. & Rios, E. Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle. J. Physiol 587, 3101-3111 (2009).
34. Franzini-Armstrong, C. Architecture and regulation of the Ca2+ delivery system in muscle cells. Appl. Physiol Nutr. Metab 34, 323-327 (2009).
35. Mosca, B. et al. Enhanced dihydropyridine receptor calcium channel activity restores muscle strength in JP45/CASQ1 double knockout mice. Nat. Commun. 4, 1541 (2013).
36. Lahat, H. et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circ. 103, 2822-2827 (2001).
37. MacLennan, D. H. & Chen, S. R. Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J. Physiol 587, 3113-3115 (2009).
38. Vasilescu, J., Guo, X. & Kast, J. Identification of protein-protein interactions using in vivo cross-linking and mass spectrometry. Proteomics. 4, 3845-3854 (2004).
39. Weerasekera, R. et al. Interactome and interface protocol (2IP): a novel strategy for high sensitivity topology mapping of protein complexes. Proteomics. 7, 3835-3852 (2007).
40. Grynkiewicz, G., Poenie, M. & Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1986).